Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 2013

View Archived Issues

Lacer prepares new strontium salts for osteoporosis

New autotaxin inhibitors claimed by Bristol-Myers Squibb

Progen Pharmaceuticals signs license term sheet for PG-545

Special protocol assessment agreement reached for phase III AEZS-108 trial

Synergy Pharmaceuticals' GC-C agonist SP-333 completes phase I trial

Emergent BioSolutions acquires rights to pandemic influenza vaccine candidate

Phase IIb trial begins for plecanatide in IBS-C

Proteome Sciences' CKI-delta inhibitors improve cognition in Alzheimer's disease model

Targeting MALT1 as a therapeutic approach for ABC-DLBCL

AI-10-49 proves effective in murine leukemia model

In vivo profiling of mGlu5 receptor modulators

Hutchison MediPharma presents novel SYK inhibitors

Swiss researchers present new antibacterial prodrugs

New beta-amyloid ligands disclosed by Italian researchers

CT Atlantic and the Universitat Zurich patent novel antibodies for cancer

Affectis Pharmaceuticals synthesizes novel P2X7 receptor antagonists

New compound demonstrates efficacy in KSHV-associated primary effusion lymphoma

New hydrid cholinesterase inhibitors divulged by Polish team

Chugai Pharmaceutical develops novel bispecific antibody for hemophilia

Xoma to study gevokizumab for noninfectious anterior scleritis

FDA grants accelerated approval for Sirturo in tuberculosis

Data presented from phase Ib trial of a ghrelin receptor agonist for type 2 diabetes

Evotec and Apeiron Biologics establish cancer immunotherapy collaboration

Third milestone in Vernalis' drug discovery collaboration with Lundbeck

FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...